English (United States)|Italiano (Italia)
English (United States) | Italiano (Italia)
Article details
Helsinn and Italfarmaco reinforce their alliance through the grant of rights to phase-III ghrelin receptor agonist Anamorelin in Italy
Created by superuser on 4/6/2016 4:45:31 PM


print
Sort by: